Stocksigma LogoStocksigma Logo

Gujarat Kidney and Super Speciality Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 3,809 (+194.6% YoY | +11.1% QoQ) ■ EBITDA: 1,022 (+99.4% YoY | +22.0% QoQ) ■ EBITDA Margin (%): 26.8 (-1281 bps YoY | +239 bps QoQ) ■ PAT: 584

Gujarat Kidney and Super Speciality Ltd - Financial Result for the Quarter ended 30th Sep'26

Gujarat Kidney and Super Speciality Ltd · Outcome · 05 Nov 2026, 12:08 am

Gujarat Kidney and Super Speciality Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 3,809 (+194.6% YoY | +11.1% QoQ) ■ EBITDA: 1,022 (+99.4% YoY | +22.0% QoQ) ■ EBITDA Margin (%): 26.8 (-1281 bps YoY | +239 bps QoQ) ■ PAT: 584 (+118.9% YoY | +12.7% QoQ) ■ EPS (INR): 0.74 (+42.3% YoY | +12.1% QoQ)

Original exchange filing (PDF)

More announcements from Gujarat Kidney and Super Speciality Ltd

All Gujarat Kidney and Super Speciality Ltd announcements